Is that medical “breakthrough” for real? Use these 8 questions to figure out if the latest cancer-related news is important, accurate, and relevant to you.
Active surveillance and watchful waiting are 2 prostate cancer treatments that people often confuse. Pathologist Oleksandr N. Kryvenko, MD, FCAP, explains exactly what they are and who may benefit from them.
As a cancer survivor, you may look forward to going back to routines from life before cancer—including a return to work. Going back to work can give an important sense of purpose, but it takes some extra planning for a smooth transition.
In this podcast, Dr. Wright and Dr. Edelson discuss the new joint clinical practice guideline on the use of neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer from the Society of Gynecologic Oncology (SGO) and the American Society of Clinical Oncology (ASCO).
After cancer treatment ends, you might not return to work because of physical, emotional, or other reasons. This can add more stress to your life. Here are some ways to ease money woes and adjust to new settings.
Biopsies are central to the diagnosis of many cancers. Pathologist Aziza Nassar, MD, sheds light on some things people should understand about biopsy.
As the ASCO Annual Meeting approaches, Dr. Schapira discusses the benefits and risks of clinical trials and the role patients can have in the future of cancer research.
Dr. Schapira reflects on costs in cancer treatment and how financial hardship is something that must be considered in the treatment plan.
Spirituality plays a key role in how many people face a cancer diagnosis. Chaplain Libby Boatwright discusses the role of a chaplain on a palliative care team.
State of Cancer Care in America: 2016 Report Finds Unprecedented Opportunity Amid Profound Turbulence
Cancer care and treatment are developing quickly but face many obstacles. ASCO President Julie Vose, MD, comments on ASCO’s third annual State of Cancer Care in America report.